Fc Receptor (FcR) and Antibody Effector Function in HIV Vaccine Discovery (R01)

The summary for the Fc Receptor (FcR) and Antibody Effector Function in HIV Vaccine Discovery (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Fc Receptor (FcR) and Antibody Effector Function in HIV Vaccine Discovery (R01): The purpose of this Funding Opportunity Announcement (FOA) is to stimulate and support investigator-driven collaborative research to: 1) probe how vaccine-elicited antibodies protect against viral acquisition via Fc receptor (FCR)-mediated mechanisms; and 2) determine the functional profiles of Fc receptor engagement in the context of immune responses elicited by protective vaccines, to inform advancement of similarly promising HIV vaccine candidates.

Federal Grant Title:	Fc Receptor (FcR) and Antibody Effector Function in HIV Vaccine Discovery (R01)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PA-17-113
Type of Funding:	Grant
CFDA Numbers:	93.855, 93.856
CFDA Descriptions:	Information not provided
Current Application Deadline:	January 7th, 2020
Original Application Deadline:	January 7th, 2020
Posted Date:	January 9th, 2017
Creation Date:	January 9th, 2017
Archive Date:	February 7th, 2020
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	January 9th, 2017

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/PA-17-113.html
Grant Announcement Contact: NIH OER Webmaster
[email protected]

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed); • Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 C...; • Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed); • Influenza Transmission Research Consortium (P01 Clinical Trial Optional); • Mucosal Immunology Studies Team (MIST) (U01 Clinical Trial Not Allowed); • Center for HIV/AIDS Vaccine Immunology (CHAVI); • Genomics of Transplantation Cooperative Research Program; • Asthma and Allergic Diseases Cooperative Research Centers
More Grants from the National Institutes of Health: • NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional); • Single Source Renewal for the Continuation of the Liver Cirrhosis Network: Scientific and ...; • NIGMS Institutional Biomedical Undergraduate Research Training (BURT) Program (T34); • Limited Competition: Outcomes of Electronic Medical Records and Genomics (eMERGE) Genomic ...; • Maximizing Investigators' Research Award (MIRA) (R35 - Clinical Trial Optional)